Versant Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Versant Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$300K	Buy	674 +47	+7%	+$20.9K	0.05%	319
2025 Q1	$304K	Buy	627 +297	+90%	+$144K	0.05%	287
2024 Q4	$133K	Buy	330 +169	+105%	+$68.1K	0.03%	248
2024 Q3	$74.9K	Buy	161 +29	+22%	+$13.5K	0.02%	322
2024 Q2	$61.9K	Buy	132 +98	+288%	+$45.9K	0.02%	320
2024 Q1	$14.2K	Hold	34	–	–	﹤0.01%	619
2023 Q4	$13.8K	Hold	34	–	–	﹤0.01%	620
2023 Q3	$11.8K	Hold	34	–	–	﹤0.01%	675
2023 Q2	$12K	Buy	34 +10	+42%	+$3.52K	﹤0.01%	708
2023 Q1	$7.56K	Hold	24	–	–	﹤0.01%	806
2022 Q4	$6.93K	Hold	24	–	–	﹤0.01%	779
2022 Q3	$7K	Hold	24	–	–	﹤0.01%	765
2022 Q2	$7K	Hold	24	–	–	﹤0.01%	774
2022 Q1	$6K	Hold	24	–	–	﹤0.01%	848
2021 Q4	$5K	Sell	24 -7	-23%	-$1.46K	﹤0.01%	922
2021 Q3	$6K	Sell	31 -51	-62%	-$9.87K	﹤0.01%	852
2021 Q2	$17K	Buy	82 +13	+19%	+$2.7K	0.01%	541
2021 Q1	$15K	Buy	69 +43	+165%	+$9.35K	0.01%	658
2020 Q4	$6K	Hold	26	–	–	﹤0.01%	885
2020 Q3	$7K	Hold	26	–	–	﹤0.01%	779
2020 Q2	$7K	Hold	26	–	–	﹤0.01%	760
2020 Q1	$6K	Buy	26 +3	+13%	+$692	﹤0.01%	723
2019 Q4	$5K	Hold	23	–	–	﹤0.01%	953
2019 Q3	$3K	Sell	23 -12	-34%	-$1.57K	﹤0.01%	1116
2019 Q2	$6K	Sell	35 -26	-43%	-$4.46K	﹤0.01%	925
2019 Q1	$11K	Hold	61	–	–	﹤0.01%	876
2018 Q4	$10K	Hold	61	–	–	﹤0.01%	833
2018 Q3	$11K	Hold	61	–	–	﹤0.01%	881
2018 Q2	$10K	Hold	61	–	–	﹤0.01%	897
2018 Q1	$9K	Hold	61	–	–	﹤0.01%	923
2017 Q4	$9K	Hold	61	–	–	﹤0.01%	949
2017 Q3	$9K	Hold	61	–	–	﹤0.01%	901
2017 Q2	$7K	Hold	61	–	–	﹤0.01%	976
2017 Q1	$6K	Hold	61	–	–	﹤0.01%	1007
2016 Q4	$4K	Sell	61 -52	-46%	-$3.41K	﹤0.01%	1087
2016 Q3	$9K	Buy	113 +15	+15%	+$1.2K	0.01%	856
2016 Q2	$8K	Hold	98	–	–	﹤0.01%	863
2016 Q1	$7K	Hold	98	–	–	﹤0.01%	881
2015 Q4	$12K	Buy	+98	New	+$12K	0.01%	686